Last reviewed · How we verify

NCT04264988

Major Pelvic Hemorrhage in Complex Surgery

Completed Last updated 11 February 2020
What this trial tests

trial testing Stopping of pelvic bleeding via several surgical methods in Pelvic Bleeding in 120 participants. Completed in 19 October 2018.

Timeline
19 April 2018
Primary endpoint
19 October 2018
19 October 2018

Quick facts

Lead sponsorAcibadem University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date19 April 2018
Primary completion19 October 2018
Estimated completion19 October 2018
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

18 and older, any sex, with Pelvic Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hemorrhage is a challenging complication of pelvic surgery. In this study, the investigators aimed to analyze the causes, management, and outcomes of major pelvic hemorrhage in patients undergoing complex abdomino-pelvic surgery. Participants who had a major intraoperative pelvic hemorrhage during complex abdomino-pelvic surgery at 11 tertiary referral centers were included. Participant characteristics, causes of hemorrhage, management strategies, and outcomes including morbidity and mortality analyses were evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04264988.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing